Loading...

Home
ETF
COAG

COAG

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

COAG News

Hemab Therapeutics Poised for Growth Post-IPO Amid Rare Disorder Treatment Progress

Latest Wall Street Rating Updates

Hemab Therapeutics Q1 Financial Overview

May 21 2026seekingalpha

Odyssey Therapeutics Raises $279 Million in Upsized IPO

May 08 2026Newsfilter

Hemab Therapeutics Successfully IPOs, Raising $346.7 Million

May 05 2026NASDAQ.COM

Strong IPO Performance from Biotech Firms

May 01 2026renaissancecapital

Hemab and Seaport Shares Surge on Strong IPO Debuts

May 01 2026seekingalpha

Hemab and Seaport Price IPOs to Raise Over $550M

May 01 2026seekingalpha

April IPO Market Rebounds with $7.3 Billion Raised

May 01 2026renaissancecapital

Hemab Therapeutics Raises $302 Million in IPO for Coagulation Disorder Treatments

May 01 2026renaissancecapital

Hemab Therapeutics Increases IPO Size to $255 Million

May 01 2026renaissancecapital